1. Home
  2. FUBO vs SYRE Comparison

FUBO vs SYRE Comparison

Compare FUBO & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUBO
  • SYRE
  • Stock Information
  • Founded
  • FUBO 2009
  • SYRE 2013
  • Country
  • FUBO United States
  • SYRE United States
  • Employees
  • FUBO N/A
  • SYRE N/A
  • Industry
  • FUBO Broadcasting
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • FUBO Industrials
  • SYRE Health Care
  • Exchange
  • FUBO Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • FUBO 1.2B
  • SYRE 1.1B
  • IPO Year
  • FUBO 2020
  • SYRE 2016
  • Fundamental
  • Price
  • FUBO $4.15
  • SYRE $15.86
  • Analyst Decision
  • FUBO Buy
  • SYRE Buy
  • Analyst Count
  • FUBO 4
  • SYRE 5
  • Target Price
  • FUBO $5.35
  • SYRE $55.00
  • AVG Volume (30 Days)
  • FUBO 13.2M
  • SYRE 414.7K
  • Earning Date
  • FUBO 10-31-2025
  • SYRE 11-06-2025
  • Dividend Yield
  • FUBO N/A
  • SYRE N/A
  • EPS Growth
  • FUBO N/A
  • SYRE N/A
  • EPS
  • FUBO 0.26
  • SYRE N/A
  • Revenue
  • FUBO $1,625,738,000.00
  • SYRE N/A
  • Revenue This Year
  • FUBO N/A
  • SYRE N/A
  • Revenue Next Year
  • FUBO $7.28
  • SYRE N/A
  • P/E Ratio
  • FUBO $15.89
  • SYRE N/A
  • Revenue Growth
  • FUBO 6.65
  • SYRE N/A
  • 52 Week Low
  • FUBO $1.21
  • SYRE $10.91
  • 52 Week High
  • FUBO $6.45
  • SYRE $40.26
  • Technical
  • Relative Strength Index (RSI)
  • FUBO 63.20
  • SYRE 42.99
  • Support Level
  • FUBO $3.90
  • SYRE $15.80
  • Resistance Level
  • FUBO $4.17
  • SYRE $17.58
  • Average True Range (ATR)
  • FUBO 0.20
  • SYRE 0.74
  • MACD
  • FUBO 0.06
  • SYRE -0.11
  • Stochastic Oscillator
  • FUBO 94.51
  • SYRE 9.78

About FUBO fuboTV Inc.

FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: